Wake Research Acquires Women's Health Care Research (San Diego)
November 16, 2021
Wake Research (M3-Wake Research) has acquired Women's Health Care Research, a San Diego-based clinical trial site led by Dr. Rovena Reagan. The acquisition expands Wake Research's national investigational site network (now five sites in California and 18 sites across seven states) and brings Dr. Reagan into the organization as a Medical Director and Investigator.
- Targets
- Women's Health Care Research
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
PhaseWell Research Acquires Chase Medical Research
March 19, 2026
Healthcare Services
PhaseWell Research, a multisite clinical research company headquartered in Nashville, announced it has acquired Chase Medical Research, a Connecticut-based clinical research site with locations in Waterbury and Hamden. The deal is intended to expand PhaseWell’s Northeast footprint and strengthen its cardiometabolic and central nervous system clinical trial capabilities in community-based settings.
-
PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
Healthcare Services
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
-
Avance Clinical Acquires C3 Research Associates to Expand into North America
September 6, 2022
Healthcare Services
Avance Clinical, a PE-backed Australian CRO, has acquired North American CRO partner C3 Research Associates to expand its later‑phase clinical trial capabilities and establish a US presence. Backed by private equity firm The Riverside Company, Avance will integrate C3 into its GlobalReady model and invest in growing its North American team to support biotechs transitioning from early‑phase studies in Australia/New Zealand to later phases in the US.
-
M3-Wake Research Acquires Multi-specialty Research Associates (MSRA)
May 18, 2022
Healthcare Services
M3-Wake Research, part of M3 Inc.'s U.S. research network, has acquired Multi-specialty Research Associates (MSRA) of Lake City, Florida. The acquisition adds an additional site to Wake Research's national footprint, expanding geographic coverage and trial access in Florida.
-
Premier Research Acquires Health Decisions
July 20, 2021
Healthcare Services
Premier Research has acquired Health Decisions, a Durham, North Carolina-based contract research organization (CRO) specializing in women’s health and diagnostic clinical trials. The acquisition expands Premier Research’s clinical development capabilities and diagnostic expertise—adding Health Decisions’ site network and experience in female-centric indications to Premier’s global CRO and consulting services.
-
Velocity Clinical Research Acquires Downtown Women's Health Care (DWHC) and Riverside Clinical Research
March 17, 2021
Healthcare Services
Velocity Clinical Research, a Durham, North Carolina-based integrated clinical site operator, acquired two U.S. clinical research sites: Downtown Women's Health Care (Denver, CO) and Riverside Clinical Research (northeast Florida). The deals expand Velocity's site footprint to 16 locations, broaden its therapeutic capabilities into renal and hepatic research, and support efforts to diversify patient recruitment for clinical trials.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.